Your browser doesn't support javascript.
loading
Agreement between a regional pharmacovigilance centre and an adjudication committee regarding adverse drug reactions on a cohort of hospitalised children.
Pages, Nicolas; Bounabi, Anissa; Boussaha, Inesse; Ndiaye, Marietou; Portefaix, Aurélie; Simeon, Gaelle; Guy, Claire; Stagnara, Jean; Paret, Nathalie; Vial, Thierry; Eftekhari, Pirayeh; Floret, Daniel; Gajdos, Vincent; Langhendries, Jean-Paul; Bleyzac, Nathalie; Alberti, Corinne; Jacqz-Aigrain, Evelyne; Nguyen, Kim An; Kassai, Behrouz.
Afiliação
  • Pages N; Centre d'investigation clinique, Inserm CIC 1407, 69003 Lyon, France.
  • Bounabi A; Centre d'investigation clinique, Inserm CIC 1407, 69003 Lyon, France.
  • Boussaha I; Centre d'investigation clinique, Inserm CIC 1407, 69003 Lyon, France.
  • Ndiaye M; Centre d'investigation clinique, Inserm CIC 1407, 69003 Lyon, France.
  • Portefaix A; Centre d'investigation clinique, Inserm CIC 1407, 69003 Lyon, France; Univ Lyon, UMR 5558, CRNS, LBBE, EMET, 69008 Lyon, France.
  • Simeon G; Univ Lyon, UMR 5558, CRNS, LBBE, EMET, 69008 Lyon, France.
  • Guy C; Centre régional de pharmacovigilance, CHU de Saint-Etienne, 42000 Saint-Etienne, France.
  • Stagnara J; Cabinet médical, 100 bis rue Montgolfier, 69006 Lyon, France.
  • Paret N; Département de pharmacologie, Hospices civils de Lyon, 69003 Lyon, France.
  • Vial T; Département de pharmacologie, Hospices civils de Lyon, 69003 Lyon, France.
  • Eftekhari P; Centre régional de pharmacovigilance, Hôpital Fernand-Widal, AP-HP, 75010 Paris, France.
  • Floret D; Université Claude-Bernard-Lyon-1, Hôpital Femme-Mère-Enfant, 69500 Bron, France.
  • Gajdos V; Département pédiatrique, Hôpital Antoine-Béclère, AP-HP, 92140 Clamart, France.
  • Langhendries JP; Département de pédiatrie and NICU, CHC Health Group, Mont-Legia, 4000 Liège-Rocourt, Belgium.
  • Bleyzac N; Service de pharmacie, Hospices civils de Lyon, Groupement hospitalier Nord, Hôpital Pierre Garraud, 69005 Lyon, France.
  • Alberti C; Centre d'investigation clinique EC 1426, Hôpital Robert-Debré/Université de Paris, AP-HP, 75019 Paris, France.
  • Jacqz-Aigrain E; Centre d'investigation clinique EC 1426, Hôpital Robert-Debré/Université de Paris, AP-HP, 75019 Paris, France.
  • Nguyen KA; Univ Lyon, UMR 5558, CRNS, LBBE, EMET, 69008 Lyon, France; Département de pharmacologie, Hospices civils de Lyon, 69003 Lyon, France; Hospices civils de Lyon, Unité néonatale de soins intensifs, Hôpital Femme-Mère-Enfant, 69500 Bron, France.
  • Kassai B; Centre d'investigation clinique, Inserm CIC 1407, 69003 Lyon, France; Univ Lyon, UMR 5558, CRNS, LBBE, EMET, 69008 Lyon, France; Service recherche et épidémiologie cliniques, Hospices civils de Lyon, Pôle Santé Publique, 69003 Lyon, France. Electronic address: Behrouz.Kassai@univ-lyon1.fr.
Therapie ; 77(4): 397-404, 2022.
Article em En | MEDLINE | ID: mdl-34998623
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Farmacovigilância Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Therapie Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Farmacovigilância Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Therapie Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França